Trinity Biotech | TRIB - Ativos





Ativos Alterar Data
Abbott USD 110.43B 23.72B 2026-03
Bayer EUR 107.29B 659M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
EDAP TMS EUR 72.06M 10.6M 2026-03
J&J USD 201.06B 167M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
OraSure Technologies USD 360.55M 18.62M 2026-06
Plus Therapeutics USD 14.03M 5.89M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Siemens EUR 167.54B 428M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Tosoh JPY 1.47T 59.99B 2026-06
Trinity Biotech USD 105.16M 1.45M 2025-12
Veracyte USD 1.49B 49.97M 2026-06